-
Something wrong with this record ?
Enhancement of musculocutaneous nerve reinnervation after vascular endothelial growth factor (VEGF) gene therapy
P. Haninec, R. Kaiser, V. Bobek, P. Dubový,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
BioMedCentral
from 2000-12-01
BioMedCentral Open Access
from 2000
Directory of Open Access Journals
from 2000
Free Medical Journals
from 2000
PubMed Central
from 2000
Europe PubMed Central
from 2000
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2000-12-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2000-01-01
Medline Complete (EBSCOhost)
from 2000-01-01
Health & Medicine (ProQuest)
from 2009-01-01
Psychology Database (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
Springer Nature OA/Free Journals
from 2000-12-01
- MeSH
- Dextrans diagnostic use MeSH
- Fluoresceins diagnostic use MeSH
- Genetic Therapy methods MeSH
- Rats MeSH
- Spinal Cord pathology MeSH
- Disease Models, Animal MeSH
- Peripheral Nervous System Diseases pathology therapy MeSH
- Nerve Fibers, Myelinated pathology MeSH
- Musculocutaneous Nerve metabolism pathology physiology MeSH
- Neurologic Examination MeSH
- Neurons metabolism pathology MeSH
- Rats, Wistar MeSH
- Forelimb physiopathology MeSH
- Nerve Regeneration genetics physiology MeSH
- Rhodamines diagnostic use MeSH
- Vascular Endothelial Growth Factor A biosynthesis metabolism therapeutic use MeSH
- Organ Size physiology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Vascular endothelial growth factor (VEGF) is not only a potent angiogenic factor but it also promotes axonal outgrowth and proliferation of Schwann cells. The aim of the present study was to quantitatively assess reinnervation of musculocutaneous nerve (MCN) stumps using motor and primary sensory neurons after plasmid phVEGF transfection and end-to-end (ETE) or end-to-side (ETS) neurorrhaphy. The distal stump of rat transected MCN, was transfected with plasmid phVEGF, plasmid alone or treated with vehiculum and reinnervated following ETE or ETS neurorrhaphy for 2 months. The number of motor and dorsal root ganglia neurons reinnervating the MCN stump was estimated following their retrograde labeling with Fluoro-Ruby and Fluoro-Emerald. Reinnervation of the MCN stumps was assessed based on density, diameter and myelin sheath thickness of regenerated axons, grooming test and the wet weight index of the biceps brachii muscles. RESULTS: Immunohistochemical detection under the same conditions revealed increased VEGF in the Schwann cells of the MCN stumps transfected with the plasmid phVEGF, as opposed to control stumps transfected with only the plasmid or treated with vehiculum. The MCN stumps transfected with the plasmid phVEGF were reinnervated by moderately higher numbers of motor and sensory neurons after ETE neurorrhaphy compared with control stumps. However, morphometric quality of myelinated axons, grooming test and the wet weight index were significantly better in the MCN plasmid phVEGF transfected stumps. The ETS neurorrhaphy of the MCN plasmid phVEGF transfected stumps in comparison with control stumps resulted in significant elevation of motor and sensory neurons that reinnervated the MCN. Especially noteworthy was the increased numbers of neurons that sent out collateral sprouts into the MCN stumps. Similarly to ETE neurorrhaphy, phVEGF transfection resulted in significantly higher morphometric quality of myelinated axons, behavioral test and the wet weight index of the biceps brachii muscles. CONCLUSION: Our results showed that plasmid phVEGF transfection of MCN stumps could induce an increase in VEGF protein in Schwann cells, which resulted in higher quality axon reinnervation after both ETE and ETS neurorrhaphy. This was also associated with a better wet weight biceps brachii muscle index and functional tests than in control rats.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13000747
- 003
- CZ-PrNML
- 005
- 20130204115227.0
- 007
- ta
- 008
- 130108s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/1471-2202-13-57 $2 doi
- 035 __
- $a (PubMed)22672575
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Haninec, Pavel $u Department of Neurosurgery, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
- 245 10
- $a Enhancement of musculocutaneous nerve reinnervation after vascular endothelial growth factor (VEGF) gene therapy / $c P. Haninec, R. Kaiser, V. Bobek, P. Dubový,
- 520 9_
- $a BACKGROUND: Vascular endothelial growth factor (VEGF) is not only a potent angiogenic factor but it also promotes axonal outgrowth and proliferation of Schwann cells. The aim of the present study was to quantitatively assess reinnervation of musculocutaneous nerve (MCN) stumps using motor and primary sensory neurons after plasmid phVEGF transfection and end-to-end (ETE) or end-to-side (ETS) neurorrhaphy. The distal stump of rat transected MCN, was transfected with plasmid phVEGF, plasmid alone or treated with vehiculum and reinnervated following ETE or ETS neurorrhaphy for 2 months. The number of motor and dorsal root ganglia neurons reinnervating the MCN stump was estimated following their retrograde labeling with Fluoro-Ruby and Fluoro-Emerald. Reinnervation of the MCN stumps was assessed based on density, diameter and myelin sheath thickness of regenerated axons, grooming test and the wet weight index of the biceps brachii muscles. RESULTS: Immunohistochemical detection under the same conditions revealed increased VEGF in the Schwann cells of the MCN stumps transfected with the plasmid phVEGF, as opposed to control stumps transfected with only the plasmid or treated with vehiculum. The MCN stumps transfected with the plasmid phVEGF were reinnervated by moderately higher numbers of motor and sensory neurons after ETE neurorrhaphy compared with control stumps. However, morphometric quality of myelinated axons, grooming test and the wet weight index were significantly better in the MCN plasmid phVEGF transfected stumps. The ETS neurorrhaphy of the MCN plasmid phVEGF transfected stumps in comparison with control stumps resulted in significant elevation of motor and sensory neurons that reinnervated the MCN. Especially noteworthy was the increased numbers of neurons that sent out collateral sprouts into the MCN stumps. Similarly to ETE neurorrhaphy, phVEGF transfection resulted in significantly higher morphometric quality of myelinated axons, behavioral test and the wet weight index of the biceps brachii muscles. CONCLUSION: Our results showed that plasmid phVEGF transfection of MCN stumps could induce an increase in VEGF protein in Schwann cells, which resulted in higher quality axon reinnervation after both ETE and ETS neurorrhaphy. This was also associated with a better wet weight biceps brachii muscle index and functional tests than in control rats.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a dextrany $x diagnostické užití $7 D003911
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fluoresceiny $x diagnostické užití $7 D005452
- 650 _2
- $a přední končetina $x patofyziologie $7 D005552
- 650 _2
- $a genetická terapie $x metody $7 D015316
- 650 _2
- $a nervus musculocutaneus $x metabolismus $x patologie $x fyziologie $7 D009138
- 650 _2
- $a nervová vlákna myelinizovaná $x patologie $7 D009413
- 650 _2
- $a regenerace nervu $x genetika $x fyziologie $7 D009416
- 650 _2
- $a neurologické vyšetření $7 D009460
- 650 _2
- $a neurony $x metabolismus $x patologie $7 D009474
- 650 _2
- $a velikost orgánu $x fyziologie $7 D009929
- 650 _2
- $a nemoci periferního nervového systému $x patologie $x terapie $7 D010523
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a rhodaminy $x diagnostické užití $7 D012235
- 650 _2
- $a mícha $x patologie $7 D013116
- 650 _2
- $a vaskulární endoteliální růstový faktor A $x biosyntéza $x metabolismus $x terapeutické užití $7 D042461
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kaiser, Radek
- 700 1_
- $a Bobek, Vladimír
- 700 1_
- $a Dubový, Petr
- 773 0_
- $w MED00008196 $t BMC neuroscience $x 1471-2202 $g Roč. 13(2012), s. 57
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22672575 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130108 $b ABA008
- 991 __
- $a 20130204115359 $b ABA008
- 999 __
- $a ok $b bmc $g 963529 $s 798911
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 13 $d 57 $i 1471-2202 $m BMC neuroscience $n BMC Neurosci $x MED00008196
- LZP __
- $a Pubmed-20130108